Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Trkola

Showing results (41-50 of 146) with videos related to

Pageof 15
Sort By:
Retrovirology|October 8, 2014
Partial rescue of V1V2 mutant infectivity by HIV-1 cell-cell transmission supports the domain's exceptional capacity for sequence variationOliver F Brandenberg, Peter Rusert, Carsten Magnus, et al.
AIDS (London, England)|January 25, 2003
HIV RNA in plasma rebounds within days during structured treatment interruptionsMarek Fischer, Roland Hafner, Christine Schneider, et al.
EMBO Molecular Medicine|June 10, 2010
HIV-1 replication activates CD4+ T cells with specificities for persistent herpes virusesAnna Haas, Manuela Rehr, Frederik Graw, et al.
Plos Pathogens|January 26, 2018
Phenotypic deficits in the HIV-1 envelope are associated with the maturation of a V2-directed broadly neutralizing antibody lineageLucia Reh, Carsten Magnus, Claus Kadelka, et al.
The Journal of Infectious Diseases|June 16, 2007
Positive in vivo selection of the HIV-1 envelope protein gp120 occurs at surface-exposed regionsBeda Joos, Marek Fischer, Andreas Schweizer, et al.
Journal of Virological Methods|November 22, 2016
MinVar: A rapid and versatile tool for HIV-1 drug resistance genotyping by deep sequencingMichael Huber, Karin J Metzner, Fabienne D Geissberger, et al.
Journal of Virology|March 14, 2003
The CCR5 and CXCR4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype CTonie Cilliers, Jabulani Nhlapo, Mia Coetzer, et al.
Journal of Virology|December 3, 2003
Human immunodeficiency virus type 1 fitness is a determining factor in viral rebound and set point in chronic infectionAlexandra Trkola, Herbert Kuster, Christine Leemann, et al.
Elife|April 19, 2021
Structure of HIV-1 gp41 with its membrane anchors targeted by neutralizing antibodiesChristophe Caillat, Delphine Guilligay, Johana Torralba, et al.
Swiss Medical Weekly|April 5, 2024
Long-term course of neutralising antibodies against SARS-CoV-2 in vaccinated and unvaccinated staff and residents in a Swiss nursing home: a cohort study 2021-2022Lisa Perrig, Irene A Abela, Nicolas Banholzer, et al.
Pageof 15

Showing results (41-50 of 146) with videos related to

Sort By:
Pageof 15
Retrovirology|October 8, 2014
Partial rescue of V1V2 mutant infectivity by HIV-1 cell-cell transmission supports the domain's exceptional capacity for sequence variationOliver F Brandenberg, Peter Rusert, Carsten Magnus, et al.
AIDS (London, England)|January 25, 2003
HIV RNA in plasma rebounds within days during structured treatment interruptionsMarek Fischer, Roland Hafner, Christine Schneider, et al.
EMBO Molecular Medicine|June 10, 2010
HIV-1 replication activates CD4+ T cells with specificities for persistent herpes virusesAnna Haas, Manuela Rehr, Frederik Graw, et al.
Plos Pathogens|January 26, 2018
Phenotypic deficits in the HIV-1 envelope are associated with the maturation of a V2-directed broadly neutralizing antibody lineageLucia Reh, Carsten Magnus, Claus Kadelka, et al.
The Journal of Infectious Diseases|June 16, 2007
Positive in vivo selection of the HIV-1 envelope protein gp120 occurs at surface-exposed regionsBeda Joos, Marek Fischer, Andreas Schweizer, et al.
Journal of Virological Methods|November 22, 2016
MinVar: A rapid and versatile tool for HIV-1 drug resistance genotyping by deep sequencingMichael Huber, Karin J Metzner, Fabienne D Geissberger, et al.
Journal of Virology|March 14, 2003
The CCR5 and CXCR4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype CTonie Cilliers, Jabulani Nhlapo, Mia Coetzer, et al.
Journal of Virology|December 3, 2003
Human immunodeficiency virus type 1 fitness is a determining factor in viral rebound and set point in chronic infectionAlexandra Trkola, Herbert Kuster, Christine Leemann, et al.
Elife|April 19, 2021
Structure of HIV-1 gp41 with its membrane anchors targeted by neutralizing antibodiesChristophe Caillat, Delphine Guilligay, Johana Torralba, et al.
Swiss Medical Weekly|April 5, 2024
Long-term course of neutralising antibodies against SARS-CoV-2 in vaccinated and unvaccinated staff and residents in a Swiss nursing home: a cohort study 2021-2022Lisa Perrig, Irene A Abela, Nicolas Banholzer, et al.
Pageof 15